The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy-Response

Clin Cancer Res. 2016 May 15;22(10):2595. doi: 10.1158/1078-0432.CCR-16-0566.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cell Line, Tumor
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Gemcitabine
  • Humans
  • Niacinamide / analogs & derivatives*
  • Niacinamide / pharmacology
  • Protein Kinase Inhibitors*

Substances

  • N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide
  • Protein Kinase Inhibitors
  • Deoxycytidine
  • Niacinamide
  • Gemcitabine